Marshall Wace North America’s ORIX IX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-14,465
Closed -$246K 1607
2021
Q1
$246K Sell
14,465
-9,485
-40% -$162K ﹤0.01% 1361
2020
Q4
$370K Sell
23,950
-6,875
-22% -$96.9K ﹤0.01% 1140
2020
Q3
$385K Buy
+30,825
New +$379K ﹤0.01% 1022
2020
Q1
Sell
-67,985
Closed -$1.13M 1413
2019
Q4
$1.13M Buy
67,985
+46,805
+221% +$751K 0.01% 698
2019
Q3
$318K Sell
21,180
-263,070
-93% -$3.94M ﹤0.01% 879
2019
Q2
$4.26M Buy
284,250
+157,140
+124% +$2.25M 0.03% 397
2019
Q1
$1.83M Buy
127,110
+77,850
+158% +$1.15M 0.01% 533
2018
Q4
$705K Buy
+49,260
New +$772K 0.01% 694

Other funds holding IX

Marshall Wace North America's IX Position: Q2 2021 in Review

Marshall Wace North America sold out of ORIX (IX) in Q2 2021, closing a stake of 14,465 shares — an estimated $246K sold.

Marshall Wace North America first reported a position in IX in Q4 2018 and held it in 8 quarters. The position peaked at $4.26M in Q2 2019. 120 funds tracked by Wall St. Rank hold IX as of Q2 2021.

  • Marshall Wace North America reported no remaining ORIX position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace North America sold 14,465 ORIX shares in Q2 2021, an estimated $246K.
  • Marshall Wace North America first reported a position in ORIX in Q4 2018 and held it in 8 quarters.
  • Marshall Wace North America's ORIX position peaked at $4.26M in Q2 2019.
  • 120 funds tracked by Wall St. Rank held ORIX as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.